E-LIB Suche - Ergebnisse für: Havelange, V.

1

Investigation Of The Gut Microbiota Composition And Activit..:

Pötgens, S.A. ; Bindels, F. ; Havelange, V....
Clinical Nutrition ESPEN. 54 (2023) - p. 596 , 2023

Link: https://doi.org/10.1016/..

2

P406: ENHANCED SIGNIFICANCE OF FLT3-ITD RESIDUAL DISEASE DE..:

Grob, T. ; Sanders, M. ; Vonk, C....
HemaSphere. 6 (2022) - p. 306-307 , 2022

Link: https://doi.org/10.1097/..

3

P699: REAL-LIFE OUTCOMES OF PONATINIB TREATMENT IN PATIENTS..:

Devos, T. ; Havelange, V. ; Theunissen, K....
HemaSphere. 6 (2022) - p. 594-595 , 2022

Link: https://doi.org/10.1097/..

4

SUN-PO113: Investigation of the Gut Microbiota Composition ..:

Pötgens, S.A. ; Bindels, F. ; Havelange, V....
Clinical Nutrition. 38 (2019) - p. S101 , 2019

Link: https://doi.org/10.1016/..

5

Paraneoplastic retinopathy and optic neuropathy with Walden..:

Ozturk, N. ; Havelange, V. ; Draganova, D..
Acta Ophthalmologica. 94 (2016) S256 - p. , 2016

Link: https://doi.org/10.1111/..

6

Secreted mutant calreticulins as rogue cytokines in myelopr..:

Pecquet, C ; Papadopoulos, N ; Balligand, T...
doi:10.1182/blood.2022016846. , 2023

Link: https://doi.org/10.1182/..

7

Therapeutic activity of GARP:TGF-β1 blockade in murine prim..:

Lecomte, S ; Devreux, J ; de Streel, G...
doi:10.1182/blood.2022017097. , 2023

Link: https://doi.org/10.1182/..

8

miR-15a-5p and miR-21-5p contribute to chemoresistance in c..:

Vandewalle, V ; Essaghir, A ; Bollaert, E...
Vandewalle , V , Essaghir , A , Bollaert , E , Lenglez , S , Graux , C , Schoemans , H , Saussoy , P , Michaux , L , Valk , P , Demoulin , JB & Havelange , V 2021 , ' miR-15a-5p and miR-21-5p contribute to chemoresistance in cytogenetically normal acute myeloid leukaemia by targeting PDCD4, ARL2 and BTG2 ' , Journal of Cellular and Molecular Medicine , vol. 25 , no. 1 , pp. 575-585 . https://doi.org/10.1111/jcmm.16110. , 2021

Link: https://pure.eur.nl/en/p..

9

Interruption or Discontinuation of Tyrosine Kinase Inhibito..:

Devos T ; Verhoef G ; Steel E...
urn:issn:0001-5792. , 2019

Link: https://orbi.uliege.be/h..

10

Discovery and functional implications of a miR-29b-1/miR-29..:

Ngankeu A ; Ranganathan P ; Havelange V...
info:eu-repo/semantics/altIdentifier/pmid/29435107. , 2018

Link: http://hdl.handle.net/11..

11

Review of current classification, molecular alterations, an..:

Havelange V ; Demoulin JB
http://www.dovepress.com/review-of-current-classification-molecular-alterations-and-tyrosine-ki-a13990. , 2013

Link: https://doaj.org/article..

12

MicroRNAs: new players in acute myeloid leukaemia:

Havelange, V ; Garzon, R ; Croce, C M
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2736837. , 2009

Link: http://www.ncbi.nlm.nih...

13

miR-15a-5p and miR-21-5p contribute to chemoresistance in c..:

Vandewalle, V. (Virginie) ; Essaghir, A. (Ahmed) ; Bollaert, E. (Emeline)...
http://repub.eur.nl/pub/132194. , 2020

Link: http://repub.eur.nl/pub/..

14

Therapeutic value of clofarabine in younger and middle-aged..:

Löwenberg, B. (Bob) ; Pabst, T. (Thomas) ; Maertens, J. (Johan)...
http://repub.eur.nl/pub/98962. , 2017

Link: http://repub.eur.nl/pub/..

15

P699: REAL-LIFE OUTCOMES OF PONATINIB TREATMENT IN PATIENTS..:

T. Devos ; V. Havelange ; K. Theunissen...
http://journals.lww.com/10.1097/01.HS9.0000845680.44858.4f. , 2022

Link: https://doi.org/10.1097/..